A five-year clinical trial of levonorgestrel silastic implants (Norplant™)

S. Diaz, M. Pavez, P. Miranda, D. N. Robertson, I. Sivin, H. B. Croxatto

Resultado de la investigación: Article

84 Citas (Scopus)

Resumen

Silastic implants containing the progestin, levonorgestrel, were tested as a long-term contraceptive system in 101 women. During five full years of use, no pregnancies occurred. The 5-year continuation rate was 54%. Menstrual irregularities were the most frequent reason for termination of use but only during the first year. More than half of the terminations for this reason were in the first year. Some of the subjects elected to continue use of the implants beyond 5 years, allowing release rate data to be obtained through 6 years. From the second through the sixth year of use, the implants delivered a constant 30 micrograms per day of levonorgestrel to the subjects, and even after six years 57% of the original steroid content remained in the capsules. Return of fertility following removal was essentially immediate and not related to time of use. Medical reasons for removal were infrequent and no pattern was discernible.

Idioma originalEnglish
Páginas (desde-hasta)447-456
Número de páginas10
PublicaciónContraception
Volumen25
N.º5
DOI
EstadoPublished - 1 ene 1982

Huella dactilar

Levonorgestrel
Clinical Trials
Progestins
Contraceptive Agents
Capsules
Fertility
Steroids
Pregnancy
baysilon

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynaecology

Citar esto

Diaz, S. ; Pavez, M. ; Miranda, P. ; Robertson, D. N. ; Sivin, I. ; Croxatto, H. B. / A five-year clinical trial of levonorgestrel silastic implants (Norplant™). En: Contraception. 1982 ; Vol. 25, N.º 5. pp. 447-456.
@article{eb03745edb14424d90770eca40eb74f0,
title = "A five-year clinical trial of levonorgestrel silastic implants (Norplant™)",
abstract = "Silastic implants containing the progestin, levonorgestrel, were tested as a long-term contraceptive system in 101 women. During five full years of use, no pregnancies occurred. The 5-year continuation rate was 54{\%}. Menstrual irregularities were the most frequent reason for termination of use but only during the first year. More than half of the terminations for this reason were in the first year. Some of the subjects elected to continue use of the implants beyond 5 years, allowing release rate data to be obtained through 6 years. From the second through the sixth year of use, the implants delivered a constant 30 micrograms per day of levonorgestrel to the subjects, and even after six years 57{\%} of the original steroid content remained in the capsules. Return of fertility following removal was essentially immediate and not related to time of use. Medical reasons for removal were infrequent and no pattern was discernible.",
author = "S. Diaz and M. Pavez and P. Miranda and Robertson, {D. N.} and I. Sivin and Croxatto, {H. B.}",
year = "1982",
month = "1",
day = "1",
doi = "10.1016/0010-7824(82)90033-6",
language = "English",
volume = "25",
pages = "447--456",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

A five-year clinical trial of levonorgestrel silastic implants (Norplant™). / Diaz, S.; Pavez, M.; Miranda, P.; Robertson, D. N.; Sivin, I.; Croxatto, H. B.

En: Contraception, Vol. 25, N.º 5, 01.01.1982, p. 447-456.

Resultado de la investigación: Article

TY - JOUR

T1 - A five-year clinical trial of levonorgestrel silastic implants (Norplant™)

AU - Diaz, S.

AU - Pavez, M.

AU - Miranda, P.

AU - Robertson, D. N.

AU - Sivin, I.

AU - Croxatto, H. B.

PY - 1982/1/1

Y1 - 1982/1/1

N2 - Silastic implants containing the progestin, levonorgestrel, were tested as a long-term contraceptive system in 101 women. During five full years of use, no pregnancies occurred. The 5-year continuation rate was 54%. Menstrual irregularities were the most frequent reason for termination of use but only during the first year. More than half of the terminations for this reason were in the first year. Some of the subjects elected to continue use of the implants beyond 5 years, allowing release rate data to be obtained through 6 years. From the second through the sixth year of use, the implants delivered a constant 30 micrograms per day of levonorgestrel to the subjects, and even after six years 57% of the original steroid content remained in the capsules. Return of fertility following removal was essentially immediate and not related to time of use. Medical reasons for removal were infrequent and no pattern was discernible.

AB - Silastic implants containing the progestin, levonorgestrel, were tested as a long-term contraceptive system in 101 women. During five full years of use, no pregnancies occurred. The 5-year continuation rate was 54%. Menstrual irregularities were the most frequent reason for termination of use but only during the first year. More than half of the terminations for this reason were in the first year. Some of the subjects elected to continue use of the implants beyond 5 years, allowing release rate data to be obtained through 6 years. From the second through the sixth year of use, the implants delivered a constant 30 micrograms per day of levonorgestrel to the subjects, and even after six years 57% of the original steroid content remained in the capsules. Return of fertility following removal was essentially immediate and not related to time of use. Medical reasons for removal were infrequent and no pattern was discernible.

UR - http://www.scopus.com/inward/record.url?scp=0019995887&partnerID=8YFLogxK

U2 - 10.1016/0010-7824(82)90033-6

DO - 10.1016/0010-7824(82)90033-6

M3 - Article

VL - 25

SP - 447

EP - 456

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -